# clm_7A1F93F832FE

subject: Amgen (/record/amgen.md)  
predicate: cash_and_equivalents  
value: 2,530,000,000 United States dollar  
valid_from: 2013-03-31  
valid_to: 2013-06-30  
published: 2013-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2E4B5E4DFAE5  
last_updated: 2026-11-08  
cite: AsOf. "Amgen cash and equivalents: 2,530,000,000 United States dollar", as of 2013-03-31 (until 2013-06-30). Claim clm_7A1F93F832FE, https://asof.is/claim/clm_7A1F93F832FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000144530513001107/0001445305-13-001107-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000144530513001107/0001445305-13-001107-index.htm (primary, SEC EDGAR 10-Q Q1 FY2013, published 2013-05-03)

## Supersedes

- [Amgen](/record/amgen.md) | cash_and_equivalents | 3,257,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_7A1F93F832FE](/claim/clm_7A1F93F832FE.md) | [clm_05AF32DE89A0](/claim/clm_05AF32DE89A0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.